ATLASATLAS fair value
£0.580
Above fair value · 14% premium
Range: £0.298–£1.12Fair valuePrice
Dr. Martens (DOCS.LSE)
Dr. Martens share price today, ATLAS forecast and fair value
Consumer Cyclical · Footwear & Accessories · London Stock Exchange · United Kingdom
£0.659▲ +0.15%
Prices as of Oct 27, 2026 · GBP
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Dr. Martens in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Dr. Martens
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Dr. Martens's fair value at about £0.580 per share (reasonable range: £0.298 to £1.12). At £0.659, the stock trades 14% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Dr. Martens a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between £0.617 and £0.703; in 9 out of 10, between £0.550 and £0.790. Estimated annual volatility is 34%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- £646M
- Market cap (USD)
- $860M
- P/E ratio
- 33.6
- Dividend yield
- 3.84%
- 52-week high
- £0.960
- 52-week low
- £0.592
- Revenue (12 months)
- £765M
- Gross margin
- 66.1%
- Operating margin
- 15.7%
- Net margin
- 3.1%
- Beta
- 0.27
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Dr. Martens sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks DOCS.LSE has traded between £0.592 and £0.960. Today it is 31.3% below that high and 11% above its low.
On the business: net margin is 3.1%; it trades at 33.6 times earnings.
Its beta is 0.27: it tends to move less than the market.
About the company
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Want to see everything about Dr. Martens?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Dr. Martens (DOCS.LSE) fair value?
About £0.580 per share according to ATLAS (reasonable range: £0.298 to £1.12). With the stock at £0.659, it is 14% above it.
What is the chance DOCS.LSE goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, DOCS.LSE ends the month between £0.617 and £0.703.
How big is Dr. Martens and what is its P/E ratio?
Dr. Martens's market capitalization is £646M. Its price-to-earnings (P/E) ratio is 33.6: you pay £33.6 for each £1.00 of yearly earnings.
Does Dr. Martens pay a dividend?
Yes. DOCS.LSE's current dividend yield is 3.84% at today's price (£0.659).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer